Cellectar Biosciences, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Cellectar Biosciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Cellectar Biosciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $87.9M, a 20.6% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $87.9M +$15M +20.6% Dec 31, 2023 10-K/A 2024-10-29
Q4 2022 $72.9M +$10.4M +16.7% Dec 31, 2022 10-K/A 2024-10-29
Q4 2021 $62.5M +$57.1M +1054% Dec 31, 2021 10-K 2023-03-09
Q4 2020 $5.42M -$44M -89% Dec 31, 2020 10-K 2022-03-21
Q4 2019 $49.4M +$8.29M +20.2% Dec 31, 2019 10-K 2021-03-02
Q4 2018 $41.1M +$2.73M +7.12% Dec 31, 2018 10-K 2020-03-09
Q4 2017 $38.4M -$15.6M -28.9% Dec 31, 2017 10-K 2019-02-26
Q4 2016 $54M +$3.95M +7.9% Dec 31, 2016 10-K 2018-03-21
Q4 2015 $50M +$3.06M +6.52% Dec 31, 2015 10-K 2017-03-15
Q4 2014 $47M +$3.06M +6.96% Dec 31, 2014 10-K/A 2016-10-20
Q4 2013 $43.9M +$4.57M +11.6% Dec 31, 2013 10-K/A 2015-05-20
Q4 2012 $39.3M +$934K +2.43% Dec 31, 2012 10-K 2014-03-19
Q4 2011 $38.4M Dec 31, 2011 10-K 2013-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.